Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
GSK126 EZH2 Inhibitor: Advanced Workflows in Cancer Epigenet
2026-06-02
GSK126, a highly selective EZH2 inhibitor, enables researchers to dissect epigenetic silencing mechanisms in cancer and beyond. This guide combines evidence-backed protocols, troubleshooting strategies, and cross-domain insights to maximize reproducibility and impact in cancer epigenetics research.
-
IgSF6 Deficiency Boosts Macrophage Antibacterial Activity vi
2026-06-02
Wu et al. (2024) reveal that loss of ER-localized immunoglobulin IgSF6 in intestinal macrophages enhances antibacterial responses by promoting endoplasmic reticulum (ER) stress and inflammation. These findings clarify a novel axis of immune regulation and suggest new avenues for modulating gut immunity in disease contexts.
-
Caspase-3 Colorimetric Assay Kit: Practical Use & Protocol G
2026-06-01
The Caspase-3 Colorimetric Assay Kit offers a robust, rapid solution for detecting DEVD-dependent caspase-3 activity, supporting apoptosis assays in cell and tissue extracts. It is best used for quantitative measurement of caspase-3 as a biomarker in apoptosis research and is not suitable for direct in vivo imaging or for non-caspase-3 protease assays.
-
(-)-Epigallocatechin Gallate (EGCG): New Horizons in Antimic
2026-06-01
Explore the multifaceted roles of (-)-Epigallocatechin gallate (EGCG) in cancer chemoprevention and antimicrobial innovation. This in-depth review highlights novel mechanistic insights and practical applications, drawing from recent breakthroughs in EGCG analog development.
-
Strategic Advances in Caspase-3 Assays for Translational Res
2026-05-31
Explore mechanistic insights and practical strategies for integrating Caspase-3 Colorimetric Assay Kits into translational pipelines, with actionable guidance for apoptosis and immunology research—anchored by recent advances in macrophage biology and endoplasmic reticulum stress.
-
Volumetric Two-Photon Brain Imaging in Freely Moving Mice
2026-05-30
The referenced study introduces the miniBB2p, a high-throughput, miniature Bessel-beam two-photon microscope capable of imaging neural calcium dynamics at subcellular resolution in freely moving mice. This innovation enables large-scale, volumetric neuronal activity mapping during natural behaviors, addressing long-standing technical limitations in in vivo neuroimaging.
-
Clozapine N-oxide (CNO): Chemogenetics and Circuit-Level Gam
2026-05-29
Explore how Clozapine N-oxide (CNO) empowers precise neuronal activity modulation and gamma oscillation research. This in-depth review highlights CNO’s unique role as a neuroscience research tool, bridges chemogenetics with cutting-edge circuit-level findings, and offers practical protocols for translational assays.
-
Fangchinoline Restores TFEB-Driven Lysosomal Biogenesis in H
2026-05-29
The reference study identifies fangchinoline as a potent modulator of lysosomal biogenesis via TFEB activation, effectively blocking H1N1 influenza virus infection. These findings highlight the therapeutic promise of targeting host lysosomal pathways to counteract viral evasion mechanisms.
-
Caspase-3 Colorimetric Assay Kit: Decoding Apoptosis and Mac
2026-05-28
Explore how the Caspase-3 Colorimetric Assay Kit enables high-sensitivity caspase activity measurement in apoptosis and immune cell research. This article uniquely connects the assay’s utility with emerging insights into macrophage function and ER stress, offering advanced, actionable guidance.
-
LMO2–LDB1 Complex Drives AML Progression via Transcriptional
2026-05-28
This study elucidates how the LMO2 transcriptional regulator, through its interaction with LDB1, promotes acute myeloid leukemia (AML) cell proliferation and survival. The findings offer new insight into the mechanistic underpinnings of AML and highlight the LMO2/LDB1 complex as a potential molecular target for future therapeutic strategies.
-
HMGB1 as an Early Serum Biomarker for Diabetic Nephropathy
2026-05-27
Peng et al. leveraged quantitative proteomics and network analysis to identify HMGB1 as a promising early serum biomarker for diabetic nephropathy progression. Their work refines biomarker discovery for early-stage disease detection, offering new avenues for noninvasive clinical monitoring.
-
Indomethacin Sodium Trihydrate: Mechanism, Protocols & Bench
2026-05-27
Indomethacin Sodium Trihydrate is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits COX-1 and COX-2, modulates the Wnt/β-catenin pathway, and is widely used in inflammation assays. Its efficacy, validated in both clinical and preclinical models, supports applications in pain, prostaglandin synthesis inhibition, and myelin regeneration research.
-
Eliminating Pollen Interference in Fluorescence-Based Hazard
2026-05-26
This study presents a robust methodology for removing pollen-induced spectral interference in excitation–emission matrix fluorescence spectroscopy, significantly improving the classification accuracy of hazardous bioaerosols. The approach enables more reliable detection of toxins and pathogenic bacteria, with broad implications for environmental monitoring and public health.
-
WP1066: Mechanistic Leverage for Translational JAK2/STAT3 Re
2026-05-26
This thought-leadership article explores the mechanistic impact and translational utility of WP1066, a potent JAK2/STAT3 inhibitor, in the context of oncology and regenerative medicine. Drawing on recent advances—including the activation of JAK2-STAT3 in immune-driven bone repair—the article provides actionable guidance for research teams seeking robust, reproducible modulation of this pathway. Strategic insights on protocol optimization, clinical translation, and future intersections with biomaterial-driven therapies are woven throughout.
-
Zolmitriptan in Migraine Research: Mechanistic Insights and
2026-05-25
Explore how Zolmitriptan, a selective 5-HT1B receptor agonist, advances migraine research through its precise mechanism of action and robust experimental protocols. This article provides deeper assay guidance and practical innovations not found in prior reviews.